PLEA News

451 – GPhC fails two out of five PSA FtP Standards

2022-02-08 16:53:36 The Professional Standards Authority has just published its review of the General Pharmaceutical Council’s performance for the period 1 March 2020 to 28 February 2022. The full report is here https://www.professionalstandards.org.uk/docs/default-source/publications/performance-reviews/performance-review-gphc-2020-21.pdf?sfvrsn=b32d4820_6 You may remember that we have reported in previous years on deficiencies found by the PSA. In

Read More »

450 – Misuse of confidential information and vicarious liabilit

2022-02-02 15:43:00 In News exactly one year ago today, we reported on the Supreme Court decision in Various Claimants v Wm Morrison Supermarkets plc [2020] UKSC 12. An employee of the supermarket business had published the confidential information of numerous fellow employees who sought to hold Morrisons vicariously liable.  The

Read More »

448 – GPhC consultation on remote hearings

2022-01-26 11:19:31 The GPhC is currently (until 8 February 2022) consulting on a proposal to allow Fitness to Practise hearings to be held remotely, extending indefinitely an arrangement that was introduced on an time-limited basis during the pandemic. A response to the consultation has been submitted on behalf of PLEA.

Read More »

445 – Fitness to practise, interim orders and freedom of expression

2021-12-05 12:45:02 In Dr Samuel White v General Medical Council [2021] EWHC 3286 (Admin), the High Court considered an interim order that curtailed freedom of expression, following the posting of views on social media, including a seven-minute video on Instagram. Although healthcare fitness to practise tribunals have considered numerous cases

Read More »

444 – Botox and dermal fillers – new law in force

2021-11-02 17:36:41 The Botulinum Toxin and Cosmetic Fillers (Children) Act 2021 came into effect on 1 October 2021. The Act, which applies only in England and Wales, started out life as a Private Members Bill. The Act creates two offences. It is an offence to administer to a person under

Read More »

443 – Recent published articles

2021-11-02 15:30:36 PLEA Executive member, Andrea James, has published a blog on the current GPhC consultation on independent prescribing https://www.brabners.com/blogs/all-change-pharmacist-independent-prescribers  Noel Wardle’s article on community pharmacy being front and centre in the COVID-19 inquiry was published by Chemist & Druggist https://www.chemistanddruggist.co.uk/CD135509/Community-pharmacy-should-be-front-and-centre-during-the-COVID-19-inquiry  Susan Hunneyball’s article on pharmacists having read-write access to patients’ records

Read More »

442 – Caldicott Guardians for pharmacies

2021-09-26 13:39:25 Last December, we reported that pharmacies may be required to appoint Caldicott Guardians this year.  The National Data Guardian has used her statutory powers to publish new guidance on the appointment, role and responsibilities of Caldicott Guardians https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1013756/Caldicott_Guardian_guidance_v1.0_27.08.21.pdf The guidance recommends the appointment of a Caldicott Guardian not just

Read More »

441 – Court of Appeal rules on consent by minors to treatment

2021-09-19 19:47:15 In Bell v Tavistock and Portman NHS Foundation Trust [2021] EWCA Civ 1363, the Court of Appeal has overtunred the Divisional Court’s decision on the the continuing practice of the Tavistock Cliniic to prescribe puberty-suppressing hormone blockers to children under the age of 18 who experience gender dysphoria.

Read More »

440 – Consent, Gillick competence and case examiners

2021-09-15 15:09:23 Consent, Gillick ccmpetence and the role of case examiners were considered in two recent cases. AB v CD [2021] EWHC 741 (Fam) concerned X, a 15-year-old who wished to continue her hormone treatment to suppress puberty. Following the earlier decision in Bell v Tavistock and Portman NHS Foundation

Read More »

436 – MHRA consulting on amending the law for point of care manufacturing

2021-08-18 11:33:04 The MHRA is conducting a consultation on Point of Care (“POC”) manufacturing https://www.gov.uk/government/consultations/point-of-care-consultation/consultation-on-point-of-care-manufacturing According to the MHRA, new types of innovative products are increasingly being manufactured at the point where a patient receives care, eg personalised medicines made for the patient either within or very close to the

Read More »

434 – GPhC warns about provision of online services

2021-08-13 12:26:49  The GPhC has written to pharmacy owners and pharmacy professionals, reminding them of the need to follow its guidance on providing pharmacy services at a distance, including on the internet. The letter https://www.pharmacyregulation.org/sites/default/files/document/patient-safety-concerns-relating-to-online-prescribing-services-letter-august-2021.pdf sent by the GPhC’s Director of Insight, Intelligence and Inspection (who spoke at the last

Read More »

433 – 2021 PLEA Annual Essay Competition Winner Announced

2021-07-28 15:42:24 Each year PLEA runs a law and ethics essay competition to foster wider thinking on issues of the day by students at UK and Ireland schools of Pharmacy.   This years competition title for consideration was “The legal and ethical implications of using volunteers to supply medicines during

Read More »

432 – GPhC annual FtP report 2020/21

2021-07-21 10:56:00  The GPhC has published its annual fitness to practise report for 2020/21. Amongst other things, the report refers to: 46 enforcement notices were served on pharmacies (45 were improvement notices and 5 imposed conditions). In the case of 35 pharmacies, enforcement action followed “intelligence-led” inspections revealing inappropriate, unusually

Read More »

431 – Product liability for health advice in a newspaper

2021-07-19 19:03:15 Directive 85/374/EEC – the Product Liability Directive – was designed to harmonise product liability laws across what is now the EU. In the UK, this gave rise to the Consumer Protection Act 1987. Under the Directive and the Act, liability for defective products is strict and a claimant

Read More »

426 – Two Bills affecting pharmacy announced in The Queen’s Speech

2021-05-13 17:07:20 The Queen’s Speech this week announced two pieces of legislation that will probably affect pharmacy practice. There will be a Health and Care Bill which will presumably implement the proposals in the Government’s recent White Paper, including subsuming Clinical Commissioning Groups into Integrated Care Systems. A Professional Qualifications

Read More »

425 – NICE clarifies cannabis guidelines so as not to deter prescribing

2021-03-31 12:29:27 According to a report in the Guardian https://www.theguardian.com/society/2021/mar/28/parents-of-boy-with-severe-epilepsy-drop-cannabis-challenge , the parents of a three-year-old have dropped a judicial review claim against NICE in which they intended to argue NICE guidelines on the prescribing of medicinal cannabis which, they said “put doctors off prescribing ‘live-saving treatment’” Prescribing cannabis was

Read More »

421 – Sad news – Professor Joy Wingfield

2021-02-17 16:12:31 We are deeply saddened to report the death from COVID-19 of our founder, Joy Wingfield. Joy was chair of the Pharmacy Law & Ethics Association until 2015. Early in Joy’s career, she was an inspector of the Royal Pharmaceutical Society of Great Britain when it was the regulator

Read More »

420 – The Medicines and Medical Devices Act 2021

2021-02-15 12:02:30 The Medicines and Medical Devices Act 2021 received the Royal Assent on 11 February 2021. To a large extent, the Act was necessitated by the pre-Brexit abolition of the European Communities Act 1972. The 1972 Act had provided powers to amend EU legislation that had been introduced in

Read More »

419 – Government response to Cumberlege Review and the Medicines & Medical Devices Bill

2021-01-12 17:43:49 Last July, we reported on the Cumberlege Review which followed the PIP breast implant scandal. The Government has just published its response to the review https://www.gov.uk/government/speeches/update-on-the-governments-response-to-the-independent-medicines-and-medical-devices-safety-review . Points of note include: The Government has tabled an amendment to the Medicines and Medical Devices Bill to establish the role

Read More »

418 – Recent articles by our members – COVID-19 vaccination, Inquest, MURs, professional conduct

2021-01-11 16:11:47 Members have written a number of articles of interest recently – Andrea James’ blog on a Coroner’s report into a death after a pharmacy error that followed a prescription change aimed at reducing pharmacy visits http://insights.brabners.com/post/102go2u/prevention-of-future-deaths-report-issued-following-community-pharmacy-error Noel Wardle’s Chemist & Druggist blog How pharmacists can avoid supplying the

Read More »

417 – Defamation in reporting fitness to practise cases

2021-01-07 18:53:37 The tort of defamation (usually involving libel) does not often impinge on pharmacy law. It is covered in the current edition of Dale & Appelbe’s Pharmacy and Medicines Law, but the forthcoming 12th edition will feature other torts instead. The recent case of Onwude v Dyer, Godlee and

Read More »

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Scroll to Top